Federal RuleAug 21
62
DOL Rewrites Disability Rules for 'Merit-Based Opportunity' Push
RuleLabor DepartmentFederal Contract Compliance Programs OfficeSignificant Wallet
117-hr-7658117th Congress
To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.
Sponsored By: Representative O'Halleran, Tom [D-AZ-1]
Unknown
Summary
This bill reauthorizes through FY2027 the Food and Drug Administration's Critical Path Public-Private Partnerships, which support medical product innovation, development, and safety.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
O'Halleran, Tom [D-AZ-1]
AZ • D
Cosponsors
Rep. Lesko, Debbie [R-AZ-8]
AZ • R
Sponsored 5/3/2022
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov